Allergan, Inc. (NYSE: AGN) today issued the following statement in response to Valeant Pharmaceuticals International (NYSE: VRX) October 27, 2014 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE